Screener
Regenxbio RGNX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Regenxbio in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Regenxbio’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336725
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Marketable securities | — | 10,785 |
| Accounts receivable | 435 | 2,312 |
| Property and equipment, net | 98,452 | 104,855 |
| Operating lease right-of-use assets | 43,867 | 47,156 |
| Restricted cash | 1,805 | 2,030 |
| Other assets | 5,902 | 4,613 |
| Total assets | $386,618 | $453,032 |
| Liabilities and Stockholders’ Equity |
Item 1. Financial Statements.
FAQ
- What is Regenxbio's operating lease ROU assets?
- Regenxbio (RGNX) reported operating lease ROU assets of $43.87M in Q2 2026.
- How has Regenxbio's operating lease ROU assets changed year-over-year?
- Regenxbio's operating lease ROU assets decreased by 13.1% year-over-year, from $50.47M to $43.87M.
- What is the long-term trend for Regenxbio's operating lease ROU assets?
- Over 5 years (2020 to 2025), Regenxbio's operating lease ROU assets has grown at a -5.9% compound annual growth rate (CAGR), from $63.82M to $47.16M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Regenxbio's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude